What Canadian Plasma Resources. does

Canadian Plasma Resources (CPR) is a Canadian source plasma collection operator and a wholly-owned subsidiary of Grifols, S.A. (NASDAQ: GRFS), the Spanish multinational pharmaceutical company. Founded in 2009 and headquartered administratively in Oakville, Ontario (with Saskatoon also listed as an operating city), CPR operates 16 plasma collection centers across Canada. The company's stated positioning is to expand Canada's domestic plasma supply, addressing the structural reality that more than 70% of plasma fractionated for Canadian patients is currently sourced from the United States.

CPR's core product is source plasma collected via plasmapheresis from compensated donors. Its operating protocol includes a four-layer donor screening process, a 60-day plasma inventory quarantine, and viral inactivation steps aligned with pharmaceutical-grade plasma specifications for downstream fractionation. The company runs a direct-to-consumer donor acquisition model, recruiting donors through its giveplasma.ca consumer platform and compensating them at up to approximately $100 per donation, supplemented by loyalty (Super Hero Rewards) and referral programs. The iCASI electronic donor questionnaire system has been deployed to digitize the intake process and standardize screening.

Commercially, CPR is structured as a vertically integrated collection arm within Grifols' global plasma supply network. Collected source plasma feeds Grifols' fractionation infrastructure, where it is manufactured into plasma-derived therapies (immunoglobulins, albumin, coagulation factors) for patients with rare and chronic conditions. CPR's effective off-take is its parent Grifols; donor-side revenue mechanics are consumer-facing (per-donation compensation) rather than enterprise contracting. Firmographic data indicates a headcount range of 11–50 employees, likely reflecting corporate and administrative staff rather than total collection-site workforce.

Name

Canadian Plasma Resources.

Legal name

Grifols Shared Services North America, Inc.

Website

https://giveplasma.ca

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Canadian Plasma Resources operates 16 plasma collection centers across Canada as a wholly-owned subsidiary of Grifols, S.A., collecting source plasma from compensated donors via plasmapheresis to supply Grifols' downstream plasma-derived therapy manufacturing network.

Ownership category

akta.pro rank

Product category

Plasma Collection Services

NAICS

Blood and Organ Banks (621991)

akta.pro primary industry

Plasma Collection & Donor Services (Plasmapheresis Centers) (HLAIAHAH)

akta.pro secondary industries

Plasma-Derived Therapy Cold Chain & Specialty Logistics (HLAIAHAL), Plasma-Derived Therapy Quality, Safety & Pharmacovigilance (Pathogen Reduction/Testing) (HLAIAHAK)

Keywords

• Plasma collection services
• Source plasma donation
• Plasmapheresis services
• Plasma protein therapies
• Paid donor programs

Headquarters

HQ city

Saskatoon

HQ country

Canada

HQ region

North America

Offices17 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Source Plasma Collection and Manufacturing: Grifols collects source plasma from paid donors at its Canadian Plasma Resources centers. The plasma is manufactured into plasma protein therapies (immunoglobulin, albumin, coagulation factors, alpha-1 antitrypsin, etc.) and sold globally to healthcare providers and patients. Revenue is generated through the sale of plasma-derived pharmaceutical products manufactured from collected raw plasma.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

Canadian Plasma Resources collects source plasma from compensated donors through plasmapheresis at 16 Health Canada-licensed collection centers across Canada. Collected plasma serves as raw material for manufacturing plasma protein therapies (immunoglobulin, albumin, coagulation factors, alpha-1 antitrypsin) used to treat patients with immune deficiencies, autoimmune diseases, hemophilia, and other conditions. The company supplements core collection with a tiered donor loyalty program and a paid referral program.

Product overview

Canadian Plasma Resources, operated by Grifols, operates a network of plasma collection centers across Canada offering plasma donation services through plasmapheresis. The core offering is source plasma collection for manufacturing into plasma protein therapies. Supporting programs include the Super Hero Rewards loyalty program (providing tiered bonus compensation based on donation frequency) and the Referral Rewards program (compensating donors for referring new donors). The company also uses an internal iCASI electronic questionnaire system for donor health screening. Donors receive compensation of up to $100 per donation, and plasma is processed into therapies for patients with immune deficiencies, autoimmune disorders, hemophilia, and other conditions.

Differentiator

Problem solved

Functional benefit

Brands

• Super Hero Rewards: Donor loyalty program enabling donors to receive bonus compensation based on donation frequency, with Orange, Silver, and Gold levels.
• Referral Rewards

Products and services

• Plasma Donation Services Collection of source plasma from qualified donors through plasmapheresis at 16 Health Canada-licensed centers across Canada. Collected plasma serves as raw material for manufacturing plasma protein therapies (immunoglobulin, albumin, coagulation factors, alpha-1 antitrypsin) for patients with immune deficiencies, autoimmune diseases, hemophilia, and related conditions.
• Super Hero Rewards Loyalty Program Tiered donor loyalty program (Orange, Silver, Gold levels) enabling donors to earn bonus compensation by donating plasma twice per week for consecutive weeks, reinforcing retention of frequent donors.
• Referral Rewards Program Paid referral program that compensates existing donors $25-$50 per referred donor who completes a plasma donation, with higher tiers based on monthly referral volume (4-6, 7-9, or 10+ referrals).

Quantifiable outcome

• Over 70% of plasma used in Canada is sourced from the US — CPR/Grifols addresses this gap by collecting plasma domestically
• +2 more outcomes

Named customers6 records

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Grifols S.A. Spanish multinational parent of CPR and one of the world's largest manufacturers of plasma-derived therapies. Comparable as the integrated owner of plasma collection, fractionation, and finished-product distribution that CPR supplies raw plasma into.
• Takeda Pharmaceutical Company: Japanese pharmaceutical major that owns BioLife Plasma Services. Comparable as the broader parent of a major paid-plasma collection competitor and a global plasma-derived therapy franchise (e.g., Gammagard, Hyqvia).

Direct peers

• Octapharma: Swiss-headquartered vertically integrated plasma therapeutics company that operates its own source plasma collection centers. Comparable as a private plasma collector and fractionator with a global footprint.
• Bio Products Laboratory (BPL): UK-based plasma fractionator with owned plasma collection operations in the U.S. Comparable as a vertically integrated competitor in source plasma collection for plasma-derived therapies.
• BioLife Plasma Services: U.S.-based plasma collection network owned by Takeda Pharmaceutical Company. Operates a comparable paid-donor, multi-center collection model with loyalty/referral programs and feeds into Takeda's plasma-derived therapy franchise.
• Kedrion Biopharma: Italian plasma-derived therapies company that collects source plasma through owned and partner centers in the U.S. and Europe. Comparable as a private integrated plasma collector/fractionator competing for the same raw-input supply chain.
• CSL Plasma: Largest global plasma collection network, subsidiary of CSL Behring (CSL Limited). Directly comparable as a paid-donor source plasma collector using a similar multi-center retail-style donor experience model.

Regional players

• Canadian Blood Services: Canada's national not-for-profit blood and plasma operator (outside Quebec). Comparable as a domestic Canadian plasma collector but operates on a non-compensated donor model, positioning it as CPR's principal public-policy counterweight.
• Héma-Québec: Québec's not-for-profit blood and plasma operator. Comparable as a Canadian regional plasma collector using a non-paid donor model, representing an alternative domestic supply model in the Canadian market.

Emerging players

• ADMA Biologics: U.S.-based commercial-stage biopharmaceutical company specializing in plasma-derived immune globulin products for immune-deficient patients. Comparable as a downstream buyer/competitor in the plasma-derived therapy value chain CPR ultimately feeds.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/giveplasma
• YouTubeyoutube.com/channel/UCrJOQHwlrB26NI9qoJ9MQbg
• Facebookfacebook.com/giveplasma
• Instagraminstagram.com/giveplasma
• LinkedInlinkedin.com/company/canadian-plasma-resources

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Canadian Plasma Resources.